Cormedix Inc 's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Cormedix Inc 's ROA in the second quarter of 2026?
Cormedix Inc achieved a return on average assets (ROA) of 1.08 % in its second quarter of 2026, this is above CRMD's average return on assets of -95.56%.
Cormedix Inc assets over the 12 months ending in its second quarter of 2026 are valued at $847 million

ROA has improved compared to -5.23% in the first quarter of 2026, due to net income growth.

However, within the Healthcare sector 200 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2026 quarter, so far to 2999, from total ROA ranking in the first quarter of 2026 at 3842.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Total Assets Change	258.16 %	574.79 %	1042.51 %	1207.84 %	114.98 %
Y / Y Net Income Change	226.41 %	186.69 %	-	-	-
Net Income (TTM) in million	9	-36	-61	139	16
Return On Assets (TTM)	1.08 %	-5.23 %	-12.07 %	45.99 %	12.77 %
CRMD's Total Ranking	# 2999	# 3842	# 89	# 438	# 3674
Total Assets (TTM) in million	905	840	886	755	253
Seq. Total Assets Change	7.72 %	-5.25 %	17.4 %	198.9 %	102.94 %
Seq. Net Income Change	67.67 %	-	-	447.52 %	47.26 %

CRMD's 5 Years Annual ROA >> Back to CRMD Management Effectiveness >> Compare CRMD ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 68
Sector	# 201
Overall	# 2148

Return On Assets Statistics
High	Average	Low
46.36 %	-95.56 %	-308.8 %
(Sep 30 2025)		(Sep 30 2018)

Financial Statements
Cormedix Inc 's Assets	$ 905 million	CRMD's Balance sheet
Cormedix Inc 's Income	$ 65 million	Quarterly CRMD's Income Statement
CRMD's Income by Division		See CRMD's Income by Division

Annual Return On Assets	(Mar 31 2025) FY 2025	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021
Y / Y Total Assets Change	25.86 %	-45.07 %	248.73 %	-10.02 %	42.76 %
Total Assets in million	150	119	216	62	69
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	21	-18	-46	-30	-28
Annual Return On Assets	13.8 %	-15.09 %	-21.42 %	-47.88 %	-40.92 %

CRMD's 5 Years Annual ROA >> Back to CRMD Management Effectiveness >> Compare CRMD ROA to its Competitors

Comment on CRMD's ROA in the fiscal year ending 2025

In the fiscal year 2025 ROA improved to 13.8 % compared to prior year, due to annual net income growth of % to $20.64 million, while value of Cormedix Inc 's overall assets grew just by 25.86 % to $149.58 million, compared to $149.58 a year before.

More Return On Assets Ratios
CRMD's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
CRMD's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for CRMD's Competitors
Subscribers only: Roa for Cormedix Inc 's Suppliers
Subscribers only: Return On Assets for CRMD's Customers

You may also want to know
CRMD's Roi	CRMD's Inventory Turnover Ratio	CRMD's Growth Rates	CRMD's Dividend Comparisons
	CRMD's Profitability Ratios	CRMD's Asset Turnover Ratio	CRMD's Dividend Growth
CRMD's Roe	CRMD's Valuation Ratios	CRMD's Financial Strength Ratios	CRMD's Dividend Payout Ratio

Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector	ROA
Vaso Corporation	2.92 %
Collegium Pharmaceutical Inc	2.72 %
National Vision Holdings Inc	2.53 %
Conmed Corporation	2.44 %
Merck and Co Inc	2.42 %
Privia Health Group Inc	2.41 %
Lifestance Health Group Inc	2.33 %
Bio rad Laboratories Inc	2.21 %
Pfizer Inc	2.12 %
Mimedx Group Inc	1.99 %
Revvity Inc	1.97 %
Alkermes Plc	1.96 %
Becton Dickinson And Company	1.77 %
Teva Pharmaceutical Industries Limited	1.77 %
Immucell Corporation	1.76 %
Envista Holdings Corporation	1.69 %
Atricure Inc	1.62 %
Black Hawk Acquisition Corporation	1.56 %
Repligen Corp	1.41 %
Omada Health Inc	1.41 %
Arvinas Inc	1.29 %
Pacira Biosciences inc	1.17 %
Waters Corporation	1.12 %
Cormedix Inc	1.11 %
Warby Parker Inc	1.05 %
Surgery Partners Inc	1.02 %
Staar Surgical Co	0.84 %
Biomarin Pharmaceutical Inc	0.82 %
Icu Medical Inc	0.75 %
Lifemd Inc	0.65 %

Date modified: 2026-09-03T11:39:59+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.